Alejandra Mendoza
Research Subjects
Alejandra Mendoza has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Stanislav Dikiy
The Scripps Research Institute
4 shared publications - Alexander Y. Rudensky
Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, USA
3 shared publications - Rockland Luke Wiseman
The Scripps Research Institute
3 shared publications - Jessica E. Thaxton
Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514
2 shared publications - Juan Sebastian Jara
Scripps Research
2 shared publications - Keishla Sánchez Ortiz
The Scripps Research Institute
2 shared publications
Latest Publications
- Open Access
Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation
T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.
Open AccessPharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation
T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.
- Open Access
Metabolically Activated Proteostasis Regulators Reduce Differentiation of CD4 + T H 17 Cells
The differentiation of naïve CD4 + T cells into effector T cell subsets such as T H 1, T H 2, T H 17 and T REG cells is governed by tightly coordinated activation programmes dependent on T cell receptor (TCR) engagement, co-stimulation, and cytokine signalling. This differentiation process involves regulation of stress-responsive signalling pathways such as the unfolded protein response (UPR) and the oxidative stress response (OSR) to adapt to the physiologic demands specific to distinct T cell subset functions. This suggests that pharmacologically targeting stress-responsive pathways offers a unique opportunity to selectively remodel the differentiation of these different T cell subsets. We previously identified compound AA147 as a metabolically activated proteostasis regulator that can induce both the ATF6 signalling arm of the UPR and, in certain cell types, the NRF2-regulated arm of the OSR.(Paxman et al., 2018; Plate et al., 2016) Here, we show that treatment with AA147 selectively reduces differentiation of pro-inflammatory T H 17 cells by promoting degradation of the lineage-specifying transcription factor RORγt, without impacting the transcription factors of other CD4 + T cell subsets. We find that AA147-dependent reduction in T H 17 differentiation is independent of ATF6 activation but involves NRF2 activation and reductions in intracellular reactive oxygen species (ROS). Apart from RORγt, we further show that AA147 decreases expression of the TCR-responsive factor IRF4, thus suppressing production of select effector cytokines across effector T cells, revealing additional ways in which this compound reshapes the activities of these essential T cell subsets. Our results demonstrate the potential for metabolically activated proteostasis regulators such as AA147 to selectively reshape T H 17 cell identity while broadly dampening effector cytokine responses across effector T cell subsets.
Open AccessMetabolically Activated Proteostasis Regulators Reduce Differentiation of CD4 + T H 17 Cells
The differentiation of naïve CD4 + T cells into effector T cell subsets such as T H 1, T H 2, T H 17 and T REG cells is governed by tightly coordinated activation programmes dependent on T cell receptor (TCR) engagement, co-stimulation, and cytokine signalling. This differentiation process involves regulation of stress-responsive signalling pathways such as the unfolded protein response (UPR) and the oxidative stress response (OSR) to adapt to the physiologic demands specific to distinct T cell subset functions. This suggests that pharmacologically targeting stress-responsive pathways offers a unique opportunity to selectively remodel the differentiation of these different T cell subsets. We previously identified compound AA147 as a metabolically activated proteostasis regulator that can induce both the ATF6 signalling arm of the UPR and, in certain cell types, the NRF2-regulated arm of the OSR.(Paxman et al., 2018; Plate et al., 2016) Here, we show that treatment with AA147 selectively reduces differentiation of pro-inflammatory T H 17 cells by promoting degradation of the lineage-specifying transcription factor RORγt, without impacting the transcription factors of other CD4 + T cell subsets. We find that AA147-dependent reduction in T H 17 differentiation is independent of ATF6 activation but involves NRF2 activation and reductions in intracellular reactive oxygen species (ROS). Apart from RORγt, we further show that AA147 decreases expression of the TCR-responsive factor IRF4, thus suppressing production of select effector cytokines across effector T cells, revealing additional ways in which this compound reshapes the activities of these essential T cell subsets. Our results demonstrate the potential for metabolically activated proteostasis regulators such as AA147 to selectively reshape T H 17 cell identity while broadly dampening effector cytokine responses across effector T cell subsets.
- Open Access
Maternal antiviral history synergizes with pregnancy and lactation to transfer intergenerational systemic immunity through IgG in milk
Maternal immune transfer is essential for early-life health, yet whether immune experiences before pregnancy shape maternal physiology to optimize immunity in subsequent offspring is unclear. Here, we show that respiratory viral infection before pregnancy confers robust protection against lethal neonatal influenza through antibodies transferred postpartum in milk. Despite the predominance of IgA in milk, antiviral IgG is indispensable for protection. Pregnancy amplifies pre-existing antiviral B cell responses, while prior infection durably reprograms the mammary gland to promote transfer of circulating antiviral IgG into milk. These antibodies retain their epitope specificity, are enriched for broadly protective influenza epitopes, remain functional after passage through the neonatal intestine, and enter offspring circulation through FcRn to provide protection beyond weaning. Natural transmission of virus from infected offspring to mothers establishes maternal immunity that protects future offspring, revealing a coordinated adaptive program that links maternal immune history, pregnancy, and lactation to optimize intergenerational immunity.
Open AccessMaternal antiviral history synergizes with pregnancy and lactation to transfer intergenerational systemic immunity through IgG in milk
Maternal immune transfer is essential for early-life health, yet whether immune experiences before pregnancy shape maternal physiology to optimize immunity in subsequent offspring is unclear. Here, we show that respiratory viral infection before pregnancy confers robust protection against lethal neonatal influenza through antibodies transferred postpartum in milk. Despite the predominance of IgA in milk, antiviral IgG is indispensable for protection. Pregnancy amplifies pre-existing antiviral B cell responses, while prior infection durably reprograms the mammary gland to promote transfer of circulating antiviral IgG into milk. These antibodies retain their epitope specificity, are enriched for broadly protective influenza epitopes, remain functional after passage through the neonatal intestine, and enter offspring circulation through FcRn to provide protection beyond weaning. Natural transmission of virus from infected offspring to mothers establishes maternal immunity that protects future offspring, revealing a coordinated adaptive program that links maternal immune history, pregnancy, and lactation to optimize intergenerational immunity.
- Open Access
T-bet Expressing B cells are Key Determinants of Protective Immunity Against Norovirus Infection
The gastrointestinal tract (GI) is the largest environmental mucosal interface and is exposed to diverse commensal and pathogenic microbes. B cells are a prevalent immune component of the GI tract and its associated secondary lymphoid organs, yet we know little about the diversity and stability of distinct transcriptional programs that modulate B cell responses against different classes of pathogens or environmental perturbations. A subset of B cells defined by expression of the transcription factor T-bet, has been canonically associated with antiviral immunity through IgG production. However, the role of T-bet expressing B cells in mucosal tissues, where IgA responses predominate, is poorly understood. Here, we identify a population of intestinal T-bet+ B cells that, in the absence of overt perturbation, constitutes a minor fraction of intestinal associated B cells and undergoes continuous turnover. In contrast, during enteric viral infection with murine norovirus (MNV), T-bet⁺ B cells undergo a marked expansion, with T-bet expression stably maintained in the majority of virus-specific B cells, including IgG2c and IgA switched B cells. Moreover, virus-reactive IgG2c and IgA B cells arise independently rather than through sequential switching, and B cell intrinsic T-bet expression is required for effective germinal center responses but dispensable for IgA class switching. Moreover, T-bet expressing B cells are required for the generation of all MNV-specific circulating IgG and mucosal IgA, and for protection upon re-encounter with the virus. Together, these findings establish T-bet expressing B cells as a specialized B cell subset essential for mucosal immunity and protection against norovirus infection.
Open AccessT-bet Expressing B cells are Key Determinants of Protective Immunity Against Norovirus Infection
The gastrointestinal tract (GI) is the largest environmental mucosal interface and is exposed to diverse commensal and pathogenic microbes. B cells are a prevalent immune component of the GI tract and its associated secondary lymphoid organs, yet we know little about the diversity and stability of distinct transcriptional programs that modulate B cell responses against different classes of pathogens or environmental perturbations. A subset of B cells defined by expression of the transcription factor T-bet, has been canonically associated with antiviral immunity through IgG production. However, the role of T-bet expressing B cells in mucosal tissues, where IgA responses predominate, is poorly understood. Here, we identify a population of intestinal T-bet+ B cells that, in the absence of overt perturbation, constitutes a minor fraction of intestinal associated B cells and undergoes continuous turnover. In contrast, during enteric viral infection with murine norovirus (MNV), T-bet⁺ B cells undergo a marked expansion, with T-bet expression stably maintained in the majority of virus-specific B cells, including IgG2c and IgA switched B cells. Moreover, virus-reactive IgG2c and IgA B cells arise independently rather than through sequential switching, and B cell intrinsic T-bet expression is required for effective germinal center responses but dispensable for IgA class switching. Moreover, T-bet expressing B cells are required for the generation of all MNV-specific circulating IgG and mucosal IgA, and for protection upon re-encounter with the virus. Together, these findings establish T-bet expressing B cells as a specialized B cell subset essential for mucosal immunity and protection against norovirus infection.
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (111) , eadz6869
Enkephalin-producing regulatory T cells in the skin restrain local inflammation through control of nociception
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we examined whether regulatory T (T reg ) cells, which suppress systemic and local inflammation, can modulate activation of peripheral neurons. Acute T reg cell “loss of function” increased neuronal activation to noxious stimuli independently of their immunosuppressive function. This activity was mediated by a T reg cell subset capable of production of enkephalins encoded by the gene Penk , whose expression is facilitated by combined TCR and glucocorticoid receptor signaling. Punctual selective depletion of Penk -expressing T reg cells or specific ablation of Penk in T reg cells increased neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of tissular T reg cells exhibits neuromodulatory activity to restrain local inflammation in the skin.
- 5 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (111) , eadz6869
Enkephalin-producing regulatory T cells in the skin restrain local inflammation through control of nociception
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we examined whether regulatory T (T reg ) cells, which suppress systemic and local inflammation, can modulate activation of peripheral neurons. Acute T reg cell “loss of function” increased neuronal activation to noxious stimuli independently of their immunosuppressive function. This activity was mediated by a T reg cell subset capable of production of enkephalins encoded by the gene Penk , whose expression is facilitated by combined TCR and glucocorticoid receptor signaling. Punctual selective depletion of Penk -expressing T reg cells or specific ablation of Penk in T reg cells increased neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of tissular T reg cells exhibits neuromodulatory activity to restrain local inflammation in the skin.
- 8 August 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (9)
Women in STEM becoming independent: People should feel free to be themselves and do great science
In this viewpoint, we hear from a cross section of women, across multiple research fields, discussing their science and the process of setting up a lab as an independent researcher.
- 8 August 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (9)
Women in STEM becoming independent: People should feel free to be themselves and do great science
In this viewpoint, we hear from a cross section of women, across multiple research fields, discussing their science and the process of setting up a lab as an independent researcher.
- Open Access
Regulatory T cells restrain skin inflammation by modulating peripheral neuron activation
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we questioned whether regulatory T cells (Treg cells), a T cell subset that suppresses systemic and local inflammation, can modulate activation of peripheral neurons. Short-term ablation of Treg cells increased neuronal activation to noxious stimuli independently from immunosuppressive function. We find that a population of skin Treg cells is highly enriched for Penk expression, a precursor for endogenous opioid enkephalins. Acute depletion of Penk-expressing Treg cells, or cell-specific ablation of Penk in Treg cells increases neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of Treg cells exhibits neuromodulatory activity to restrain inflammation.
Open AccessRegulatory T cells restrain skin inflammation by modulating peripheral neuron activation
The skin integrates diverse signals discerned by sensory neurons and immune cells to elicit adaptive responses to a range of stresses. Considering interactions between nervous and immune systems, we questioned whether regulatory T cells (Treg cells), a T cell subset that suppresses systemic and local inflammation, can modulate activation of peripheral neurons. Short-term ablation of Treg cells increased neuronal activation to noxious stimuli independently from immunosuppressive function. We find that a population of skin Treg cells is highly enriched for Penk expression, a precursor for endogenous opioid enkephalins. Acute depletion of Penk-expressing Treg cells, or cell-specific ablation of Penk in Treg cells increases neuronal activation in response to noxious stimuli and associated inflammation. Our study indicates that a population of Treg cells exhibits neuromodulatory activity to restrain inflammation.
- 15 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (60)
Assembly of a spatial circuit of T-bet–expressing T and B lymphocytes is required for antiviral humoral immunity
Effective antiviral immunity requires generation of T and B lymphocytes expressing the transcription factor T-bet, a regulator of type 1 inflammatory responses. Using T-bet expression as an endogenous marker for cells participating in a type 1 response, we report coordinated interactions of T-bet–expressing T and B lymphocytes on the basis of their dynamic colocalization at the T cell zone and B follicle boundary (T-B boundary) and germinal centers (GCs) during lung influenza infection. We demonstrate that the assembly of this circuit takes place in distinct anatomical niches within the draining lymph node, guided by CXCR3 that enables positioning of TH1 cells at the T-B boundary. The encounter of B and TH1 cells at the T-B boundary enables IFN-γ produced by the latter to induce IgG2c class switching. Within GCs, T-bet+ TFH cells represent a specialized stable sublineage required for GC growth but dispensable for IgG2c class switching. Our studies show that during respiratory viral infection, T-bet–expressing T and B lymphocytes form a circuit assembled in a spatiotemporally controlled manner that acts as a functional unit enabling a robust and coherent humoral response tailored for optimal antiviral immunity.
- 15 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 6 (60)
Assembly of a spatial circuit of T-bet–expressing T and B lymphocytes is required for antiviral humoral immunity
Effective antiviral immunity requires generation of T and B lymphocytes expressing the transcription factor T-bet, a regulator of type 1 inflammatory responses. Using T-bet expression as an endogenous marker for cells participating in a type 1 response, we report coordinated interactions of T-bet–expressing T and B lymphocytes on the basis of their dynamic colocalization at the T cell zone and B follicle boundary (T-B boundary) and germinal centers (GCs) during lung influenza infection. We demonstrate that the assembly of this circuit takes place in distinct anatomical niches within the draining lymph node, guided by CXCR3 that enables positioning of TH1 cells at the T-B boundary. The encounter of B and TH1 cells at the T-B boundary enables IFN-γ produced by the latter to induce IgG2c class switching. Within GCs, T-bet+ TFH cells represent a specialized stable sublineage required for GC growth but dispensable for IgG2c class switching. Our studies show that during respiratory viral infection, T-bet–expressing T and B lymphocytes form a circuit assembled in a spatiotemporally controlled manner that acts as a functional unit enabling a robust and coherent humoral response tailored for optimal antiviral immunity.